BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170925
DTEND;VALUE=DATE:20170928
DTSTAMP:20260515T132412
CREATED:20170620T091806Z
LAST-MODIFIED:20170620T092213Z
UID:2329-1506297600-1506556799@www.pharmajournalist.com
SUMMARY:FierceBiotech 2nd Drug Development Forum
DESCRIPTION:The 2nd annual FierceBiotech Drug Development Forum will draw together the industry’s executive decision-makers\, to help guide your companies to success throughout the entire life cycle – both for products and for companies themselves. This event gives biopharma leaders the skills to improve their partnership strategies with larger companies\, financing sources and outsourced research partners. Our experienced and savvy executive-level speaking faculty will help you shape\, select and pitch the best partnerships for drug development\, while successfully navigating the financial and regulatory changes arising from a new administration. Target your learning opportunities toward four full-length tracks: Strategic Deal-Making\, Clinical Research Outsourcing & Technology\, Improving R&D Outcomes and Digital Technology & Real-World Evidence. We invite you to join this unparalleled opportunity to work with your peers toward a quantum leap in drug development productivity and speed! \nTo learn more about this event\, and to register online\, visit http://bit.ly/2sOSHSE
URL:https://www.pharmajournalist.com/event/fiercebiotech-2nd-drug-development-forum/
LOCATION:Renaissance Boston Waterfront Hotel\, 606 Congress Street\, Boston\, MA 02210
ORGANIZER;CN="ExL Events":MAILTO:amagnolo@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170925
DTEND;VALUE=DATE:20170930
DTSTAMP:20260515T132412
CREATED:20170626T071104Z
LAST-MODIFIED:20170627T074854Z
UID:2392-1506297600-1506729599@www.pharmajournalist.com
SUMMARY:15th Annual Global Forum
DESCRIPTION:Returning for its 15th iteration\, the world’s largest event for temperature-controlled life science supply chains heads back to Chicago this year with a focus on the next generation of temperature control! Join 850+ attendees from 30+ countries for five days of master classes\, workshops\, track sessions\, panel discussions\, roundtables\, and more.  With the Global Forum\, your company will meet emerging and ongoing challenges for 2017 and beyond. \nTo learn more about this event visit http://bit.ly/2tKDbVk \nDownload the Event Agenda: http://bit.ly/2taKpon \nTo register please visit http://bit.ly/2sQSeN9
URL:https://www.pharmajournalist.com/event/15th-annual-global-forum/
LOCATION:Hyatt Regency McCormick Place\, Chicago\, IL
ORGANIZER;CN="IQPC North America":MAILTO:enquiry@iqpc.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20170926
DTEND;VALUE=DATE:20170928
DTSTAMP:20260515T132412
CREATED:20170817T001521Z
LAST-MODIFIED:20170817T002251Z
UID:2889-1506384000-1506556799@www.pharmajournalist.com
SUMMARY:BioPharm America™ 2017
DESCRIPTION:BioPharm America™ 2017—10th Annual International Partnering Conference\nAccess capital\, innovation and partners \nBioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Now in its tenth year\, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms\, major pharmaceutical companies\, academic institutions and biotechnology companies of every size and stage\, from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. \n \nA primary focus of BioPharm America™ is the one-to-one meetings driven by partneringONE®\, the industry’s most robust software platform. Delegates can request and schedule meetings tailored to their strategic business goals to create a dynamic personalized agenda that includes regular alerts for further meeting opportunities. \nThe impetus behind this intensive business development activity is a two-day \nconference program that features thought leaders and executives from across the life science industry. To help bring attention to early stage projects and small entrepreneurial companies\, BioPharm America features special tracks specifically designed for startups and young companies to get on the radar of the global life science community and to make the connections that matter. Engaging panel discussions cover topics of interest to dealmakers including licensing\, investment and business development. \nLeading pharmaceutical companies attend BioPharm America in search of innovation\, such as Amgen\, AstraZeneca\, Bayer HealthCare\, Biogen Idec\, Boehringer Ingelheim\, Genentech\, Sanofi/Genzyme\, Gilead\, Ironwood\, Johnson & Johnson Innovation\, Merck\, Novo Nordisk\, Nycomed\, Pfizer\, and Shire. Held in Boston each September\, the event attracted 850+ delegates from 525 companies who participated in 2\,350+ scheduled one-to-one meetings in 2016. \nTo learn more about this event\, and to register online\, visit https://goo.gl/SZfnmi \nProducer: \nEBD Group\, Inc.\nEBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions\, conferences and training in the world.  \nContact: \nCassidy Hamilton\nEBD Group\nCarlsbad\, CA\n+1 760 930 0500\nchamilton@ebdgroup.com \n 
URL:https://www.pharmajournalist.com/event/biopharm-america-2017/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="EBD Group%2C Inc.":MAILTO:chamilton@ebdgroup.com
END:VEVENT
END:VCALENDAR